Matthew Nelson, PhD
Board of Directors, GGMC
Vice President, Genetics and Genomics, Deerfield Discovery and Development
Matthew Nelson, Ph.D., is a Vice President, Genetics and Genomics, Deerfield Discovery and Development, and joined the firm in 2019. He is also Chief Executive Officer of Deerfield’s affiliate, Genscience, a tech-focused company to improve integration of genetic evidence into drug discovery. Prior to joining Deerfield in 2019, Dr. Nelson spent almost 15 years at GlaxoSmithKline and was most recently the Head of Genetics. Prior to GlaxoSmithKline, Dr. Nelson was the Director of Biostatistics at Sequenom. He is co-author on >80 publications, including several cited >1,000 times. He began his career as an information scientist at Esperion Therapeutics. Dr. Nelson was an Adjunct Associate Professor of Biostatistics at the University of North Carolina from 2010 to 2016. He holds a Ph.D. in Human Genetics and an M.A. in Statistics from the University of Michigan and obtained his B.S. in Molecular Biology from Brigham Young University.